Earnings Feed
Start Free
Ocuphire Pharma, Inc.·4

Nov 25, 7:42 PM ET

MEYER ALAN R 4

4 · Ocuphire Pharma, Inc. · Filed Nov 25, 2020

Insider Transaction Report

Form 4
Period: 2020-11-19
Ocuphire Pharma, Inc.OCUP
MEYER ALAN R
Director
Transactions
  • Purchase

    Common Stock

    2020-11-19+1,771→ 487,029 total
  • Purchase

    Series A Warrant (right to buy)

    2020-11-19+2,679→ 2,679 total
    Exercise: $4.48From: 2020-11-19Exp: 2025-11-19→ Common Stock (2,679 underlying)
  • Purchase

    Series B Warrant (right to buy)

    2020-11-19+315→ 315 total
    Exercise: $0.00From: 2020-11-19Exp: 2022-01-28→ Common Stock (315 underlying)
Footnotes (2)
  • [F1]The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $10,000.
  • [F2]Subject to adjustment based on certain price reset provisions.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4